Age-related changes in plasma androgen levels and their association with cardiovascular risk factors in male Japanese office workers

Geriatrics and Gerontology International

Volumn 10, Issue 1, 2010, Pages 32-39

  Fukai, Shiho ^a   Akishita, Masahiro ^a   Miyao, Mariko ^a   Ishida, Kiyoshi ^b   Toba, Kenji ^c   Ouchi, Yasuyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Clinic   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging male; Dehydroepiandrosterone sulfate; Hypogonadism; Testosterone

Indexed keywords

ANDROGEN; GLUCOSE; HEMOGLOBIN; LIPID; PRASTERONE; TESTOSTERONE; URIC ACID;

ADULT; AGING; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE ACTION; HUMAN; JAPANESE; LIPID BLOOD LEVEL; MALE; OFFICE WORKER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGING; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; TESTOSTERONE;

EID: 73049091170     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00552.x     Document Type: Article

References (40)

1. Wang C, Nieschlag E, Swerdloff RS. ISSAM ISA, EAU, EAA and ASA recommendations, investigation, treatment and monitoring of late-onset hypogonadism in males. Eur J Endocrinol 2008, 159:507-514.
2. Iwamoto T, Yanase T, Horie H, Namiki M, Okuyama A. Late-onset hypogonadism (LOH) and androgens: Validity of the measurement of free testosterone levels in the diagnostic criteria in Japan. Int J Urol 2009, 16:168-174.
3. Feldman HA, Longcope C, Derby CA. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002, 87:589-598.
4. Harman SM, Metter EJ, Tobin JD. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001, 86:724-731.
5. Muller M, den Tonkellar I, Thijssen JHH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40-80 years. European Journal of Endocrinology 2003, 149:583-589.
6. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000, 21:697-738.
7. Couillard C, Gagnon J, Bergeron J. Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE family study. J Clin Endocrinol Metab 2000, 85:1026-1031.
8. Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol 1992, 2:675-682.
9. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 1990, 132:895-901.
10. Andersson B, Vermeulen A, Marin P, Bjorntorp P, Lissner L. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994, 17:405-411.
11. Chang TC, Tung CC, Hsiao YL. Hormonal changes in elderly men with non-insulin-dependent diabetes-mellitus and the hormonal relationships to abdominal adiposity. Gerontology 1994, 40:260-267.
12. Simon D, Charles MA, Nahoul K. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study. J Clin Endocrinol Metab 1997, 82:682-685.
13. Stellato RK, Feldman HA, Hamdy O. Testosterone, sex hormone? binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts Male Aging Study. Diabetes Care 2000, 23:490-494.
14. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988, 78:539-545.
15. Fogari R, Preti P, Zoppi A. Serum testosterone levels and arterial blood pressure in the elderly. Hypertens Res 2005, 28:625-630.
16. Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens 1988, 6:329-332.
17. Hughes GS, Mathur RS, Margolius HS. Sex steroid hormones are altered in essential hypertension. J Hypertens 1989, 7:181-187.
18. Hak AE, Witteman JC, de Jong FH. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002, 87:3632-3639.
19. Bjornerem A, Straume B, Midtby M. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metab 2004, 89:6039-6047.
20. Tannenbaum C, Barrett-Connor E, Laughlin GA. A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study. Eur J Endocrinol 2004, 151:717-725.
21. Svartberg J, von Mühlen D, Sundsfjord J, Jorde R. Waist circumference and testosterone levels in community dwelling men. The Tromsø study. Eur J Epidemiol 2004, 19:657-663.
22. Pasquali R, Casimirri F, Cantobelli S. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991, 40:101-104.
23. Leenen R, van der Koy K, Seidell JC, Deurenberg P, Kopperschaar HPF. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 1994, 78:1515-1520.
24. Saad F, Gooren L, Haider A. Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome. Andrologia 2008, 40:44-48.
25. Laaksonen DE, Niskanen L, Punnonen K. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 2005, 90:712-719.
26. Vermeulen A. Androgen replacement therapy in the aging male. A critical evaluation. J Clin Endocrinol Metab 2001, 86:2380-2390.
27. Ferrucci L, Maggio M, Bandinelli S. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006, 166:1380-1388.
28. Perretta M, Valladares L, Garrido F. Hormonal control of gene expression: differential activation of rat bone marrow RNA polymerases by erythropoietin and testosterone. Arch Biol Med Exp (Santiago) 1979, 12:309-318.
29. Fried W, Gurney CW. The erythropoietic-stimulating effects of androgens. Ann N Y Acad Sci 1968, 149:356-365.
30. Rishpon-Meyerstein N, Kilbridge T, Simone J. The effect of testosterone on erythropoietin levels in anemic patients. Blood 1968, 31:453-460.
31. Naets JP, Wittek M. The mechanism of action of androgens on erythropoiesis. Ann N Y Acad Sci 1968, 149:366-376.
32. Naets JP, Wittek M. Erythropoiesis in anephric man. Lancet 1968, 1:941-943.
33. Demirbag R, Yilmaz R, Ulucay A. The inverse relationship between thoracic aortic intima media thickness and testosterone level. Endocr Res 2005, 31:335-344.
34. Nishiyama T, Ishizaki F, Anraku T. The influence of androgen deprivation therapy on metabolism in patients with prostate cancer. J Clin Endocrinol Metab 2005, 90:657-660.
35. Yahyaoui R, Esteva I, Haro-Mora JJ. Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab 2008, 93:2230-2233.
36. Pizzichini M, Leoncini R, Vannoni D, Marinello E, Pagani R. The influence of testosterone on purine nucleotide metabolism in rat liver. Life Sci 1995, 57:2127-2135.
37. Adamopoulos D, Vlassopoulos C, Seitanides B. The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh) 1977, 85:198-208.
38. Fox IH. Metabolic basis for disorders of purine nucleotide degradation. Metabolism 1981, 30:616-634.
39. Fabregat I, Revilla E, Machado A. Short-term control of the pentose phosphate cycle by insulin could be modulated by NADPH/NADP ratio in rat adipocytes and hepatocytes. Biochem Biophys Res Commun 1987, 146:920-925.
40. Facchini F, Chen YD, Hollenbeck CB. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991, 266:3008-3011.